Stock Information for XERS

Overview of XERS

XERS, also known as Xeris Biopharma Holdings Inc, is a company in the Health Care sector. Xeris Biopharma Holdings's website is https://www.xerispharma.com.

Market Capitalization

XERS has a market cap of $481.53 million with 149,081,461.00 shares outstanding as of Thu, Oct 31, 2024.

Stock Charts

The XERS stock charts offer a comprehensive, real-time view of Xeris Biopharma Holdings's stock performance. Powered by TradingView, these interactive charts provide investors with a dynamic and detailed visualization of XERS's market activity.

Key features of the XERS stock charts include:

• Real-Time Data: Get up-to-the-minute updates on Xeris Biopharma Holdings's stock price, ensuring you have the latest information at your fingertips.
• Customizable Time Frames: Analyze XERS's performance over various periods, from intraday movements to long-term trends. Easily switch between daily, weekly, monthly, and yearly views.
• Technical Indicators: Utilize a wide array of technical indicators, such as moving averages, RSI, MACD, and more, to perform in-depth analysis of XERS's stock movements.
• Drawing Tools: Enhance your analysis with TradingView's extensive drawing tools. Add trend lines, channels, Fibonacci retracements, and other annotations to your charts.
• Comparative Analysis: Compare XERS's performance against other stocks, indices, or financial instruments to gain a broader market perspective.
• User-Friendly Interface: The interactive nature of the charts allows you to zoom in, pan across different periods, and hover over data points for detailed information, making it easy to track and analyze XERS's stock performance.

Whether you're a day trader looking for quick insights or a long-term investor analyzing market trends, the XERS stock charts provide all the tools you need to make informed decisions. Dive into the data and explore how Xeris Biopharma Holdings is performing in the market today.

Comprehensive Stock Forecast for XERS

Understanding the future trajectory of a stock is crucial for investors, and XERS is no exception. With numerous analysts and financial experts weighing in, it’s essential to have a comprehensive overview of what to expect. Below, we explore various aspects of the XERS stock forecast, drawing insights from different time frames and sources to provide a well-rounded perspective.

The forecast for XERS extends through multiple years, with detailed projections for 2024, 2025, 2029, 2034, and even as far as 2034. These projections are based on various factors, including market trends, financial health, and overall economic conditions. Notable sources such as FintechZoom, CNN Money, Zacks, and WalletInvestor offer diverse viewpoints, ensuring that investors get a holistic understanding of the potential growth or decline of XERS.

In the short term, predictions for XERS in the upcoming months or years (2024, 2025, 2029) are often influenced by current market performance and recent financial reports. For the long term, forecasts for 2029, 2034, and beyond consider broader economic indicators and industry trends. Analysts also provide specific outlooks, like the 5-year forecast, to help investors plan their strategies accordingly.

Moreover, platforms like CNBC and Yahoo Finance provide detailed analysis and expert opinions that contribute significantly to the stock’s forecast. Whether you’re looking for tomorrow’s prediction or the long-term outlook, these insights are invaluable. By examining forecasts from various credible sources, investors can make informed decisions based on a well-rounded view of the potential future of XERS.